IL-17 producing cells in host defense and atopy

Current Opinion in Immunology

Volumn 23, Issue 6, 2011, Pages 784-788

  Milner, Joshua D ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 17;

ALLERGIC RHINITIS; ALLERGY; ASTHMA; ATOPIC DERMATITIS; ATOPY; AUTOIMMUNITY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DRUG TARGETING; GENETIC DISORDER; HOST RESISTANCE; HUMAN; IMMUNE DEFICIENCY; INFECTION; INFECTION SENSITIVITY; NONHUMAN; REVIEW; TH17 CELL;

ANAPHYLAXIS; ANIMALS; ASTHMA; BASOPHILS; DERMATITIS, ATOPIC; HUMANS; INTERLEUKIN-17;

EID: 82955212791     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2011.09.006     Document Type: Review

References (43)

1. Minegishi Y., Saito M., Tsuchiya S., Tsuge I., Takada H., Hara T., Kawamura N., Ariga T., Pasic S., Stojkovic O., et al. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature 2007, 448:1058-1062.
2. Holland S.M., DeLeo F.R., Elloumi H.Z., Hsu A.P., Uzel G., Brodsky N., Freeman A.F., Demidowich A., Davis J., Turner M.L., et al. STAT3 mutations in the hyper-IgE syndrome. The New England Journal of Medicine 2007, 357:1608-1619.
3. Milner J.D., Brenchley J.M., Laurence A., Freeman A.F., Hill B.J., Elias K.M., Kanno Y., Spalding C., Elloumi H.Z., Paulson M.L., et al. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 2008, 452:773-776.
4. de Beaucoudrey L., Puel A., Filipe-Santos O., Cobat A., Ghandil P., Chrabieh M., Feinberg J., von Bernuth H., Samarina A., Janniere L., et al. Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells. The Journal of Experimental Medicine 2008, 205:1543-1550.
5. Ma C.S., Chew G.Y., Simpson N., Priyadarshi A., Wong M., Grimbacher B., Fulcher D.A., Tangye S.G., Cook M.C. Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3. The Journal of Experimental Medicine 2008, 205:1551-1557.
6. Al Khatib S., Keles S., Garcia-Lloret M., Karakoc-Aydiner E., Reisli I., Artac H., Camcioglu Y., Cokugras H., Somer A., Kutukculer N., et al. Defects along the T(H)17 differentiation pathway underlie genetically distinct forms of the hyper IgE syndrome. The Journal of Allergy and Clinical Immunology 2009, 124:342-348. 348 e341-e345.
7. Puel A., Doffinger R., Natividad A., Chrabieh M., Barcenas-Morales G., Picard C., Cobat A., Ouachee-Chardin M., Toulon A., Bustamante J., et al. Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I. The Journal of Experimental Medicine 2010, 207:291-297.
8. Kisand K., Boe Wolff A.S., Podkrajsek K.T., Tserel L., Link M., Kisand K.V., Ersvaer E., Perheentupa J., Erichsen M.M., Bratanic N., et al. Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines. The Journal of Experimental Medicine 2010, 207:299-308.
9. Ng W.F., von Delwig A., Carmichael A.J., Arkwright P.D., Abinun M., Cant A.J., Jolles S., Lilic D. Impaired T(H)17 responses in patients with chronic mucocutaneous candidiasis with and without autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. The Journal of Allergy and Clinical Immunology 2010, 126:1006-1015. 1015 e1001-e1004.
10. Ferwerda B., Ferwerda G., Plantinga T.S., Willment J.A., van Spriel A.B., Venselaar H., Elbers C.C., Johnson M.D., Cambi A., Huysamen C., et al. Human dectin-1 deficiency and mucocutaneous fungal infections. The New England Journal of Medicine 2009, 361:1760-1767.
11. Marodi L., Erdos M. Dectin-1 deficiency and mucocutaneous fungal infections. The New England Journal of Medicine 2010, 362:367. author reply 367-368.
12. van de Veerdonk F.L., Plantinga T.S., Hoischen A., Smeekens S.P., Joosten L.A., Gilissen C., Arts P., Rosentul D.C., Carmichael A.J., Smits-van der Graaf C.A., et al. STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis. The New England Journal of Medicine 2011, 365:54-61.
13. Liu L., Okada S., Kong X.F., Kreins A.Y., Cypowyj S., Abhyankar A., Toubiana J., Itan Y., Audry M., Nitschke P., et al. Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. The Journal of Experimental Medicine 2011.
14. Puel A., Cypowyj S., Bustamante J., Wright J.F., Liu L., Lim H.K., Migaud M., Israel L., Chrabieh M., Audry M., et al. Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity. Science 2011, 332:65-68.
15. Minegishi Y., Saito M., Nagasawa M., Takada H., Hara T., Tsuchiya S., Agematsu K., Yamada M., Kawamura N., Ariga T., et al. Molecular explanation for the contradiction between systemic Th17 defect and localized bacterial infection in hyper-IgE syndrome. The Journal of Experimental Medicine 2009, 206:1291-1301.
16. Conti H.R., Baker O., Freeman A.F., Jang W.S., Holland S.M., Li R.A., Edgerton M., Gaffen S.L. New mechanism of oral immunity to mucosal candidiasis in hyper-IgE syndrome. Mucosal Immunology 2011.
17. Hanifin J.M., Homburger H.A. Staphylococcal colonization, infection, and atopic dermatitis - association not etiology. The Journal of Allergy and Clinical Immunology 1986, 78:563-566.
18. Saito M., Nagasawa M., Takada H., Hara T., Tsuchiya S., Agematsu K., Yamada M., Kawamura N., Ariga T., Tsuge I., et al. Defective IL-10 signaling in hyper-IgE syndrome results in impaired generation of tolerogenic dendritic cells and induced regulatory T cells. The Journal of Experimental Medicine 2011, 208:235-249.
19. Oyoshi M.K., Murphy G.F., Geha R.S. Filaggrin-deficient mice exhibit TH17-dominated skin inflammation and permissiveness to epicutaneous sensitization with protein antigen. The Journal of Allergy and Clinical Immunology 2009, 124:485-493. 493 e481.
20. He R., Kim H.Y., Yoon J., Oyoshi M.K., MacGinnitie A., Goya S., Freyschmidt E.J., Bryce P., McKenzie A.N., Umetsu D.T., et al. Exaggerated IL-17 response to epicutaneous sensitization mediates airway inflammation in the absence of IL-4 and IL-13. The Journal of Allergy and Clinical Immunology 2009, 124. 761-770 e761.
21. Hayashida S., Uchi H., Moroi Y., Furue M. Decrease in circulating Th17 cells correlates with increased levels of CCL17, IgE and eosinophils in atopic dermatitis. Journal of Dermatological Science 2011, 61:180-186.
22. Guttman-Yassky E., Lowes M.A., Fuentes-Duculan J., Zaba L.C., Cardinale I., Nograles K.E., Khatcherian A., Novitskaya I., Carucci J.A., Bergman R., et al. Low expression of the IL-23/Th17 pathway in atopic dermatitis compared to psoriasis. Journal of Immunology 2008, 181:7420-7427.
23. Koga C., Kabashima K., Shiraishi N., Kobayashi M., Tokura Y. Possible pathogenic role of Th17 cells for atopic dermatitis. The Journal of Investigative Dermatology 2008, 128:2625-2630.
24. Toda M., Leung D.Y., Molet S., Boguniewicz M., Taha R., Christodoulopoulos P., Fukuda T., Elias J.A., Hamid Q.A. Polarized in vivo expression of IL-11 and IL-17 between acute and chronic skin lesions. The Journal of Allergy and Clinical Immunology 2003, 111:875-881.
25. Nograles K.E., Suarez-Farinas M., Shemer A., Fuentes-Duculan J., Chiricozzi A., Cardinale I., Zaba L.C., Kikuchi T., Ramon M., Bergman R., et al. Atopic dermatitis keratinocytes exhibit normal T(H)17 cytokine responses. The Journal of Allergy and Clinical Immunology 2010, 125:744-746. 746 e741-746 e742.
26. Eyerich K., Pennino D., Scarponi C., Foerster S., Nasorri F., Behrendt H., Ring J., Traidl-Hoffmann C., Albanesi C., Cavani A. IL-17 in atopic eczema: linking allergen-specific adaptive and microbial-triggered innate immune response. The Journal of Allergy and Clinical Immunology 2009, 123. 59-66 e54.
27. Newcomb D.C., Boswell M.G., Zhou W., Huckabee M.M., Goleniewska K., Sevin C.M., Hershey G.K., Kolls J.K., Peebles R.S. Human TH17 cells express a functional IL-13 receptor and IL-13 attenuates IL-17A production. The Journal of Allergy and Clinical Immunology 2011, 127:1006-1013. e1001-e1004.
28. Wang Y.H., Voo K.S., Liu B., Chen C.Y., Uygungil B., Spoede W., Bernstein J.A., Huston D.P., Liu Y.J. A novel subset of CD4(+) T(H)2 memory/effector cells that produce inflammatory IL-17 cytokine and promote the exacerbation of chronic allergic asthma. The Journal of Experimental Medicine 2010, 207:2479-2491.
29. Raymond M., Van V.Q., Wakahara K., Rubio M., Sarfati M. Lung dendritic cells induce T(H)17 cells that produce T(H)2 cytokines, express GATA-3, and promote airway inflammation. The Journal of Allergy and Clinical Immunology 2011, 128:192-201.
30. Cosmi L., Maggi L., Santarlasci V., Capone M., Cardilicchia E., Frosali F., Querci V., Angeli R., Matucci A., Fambrini M., et al. Identification of a novel subset of human circulating memory CD4(+) T cells that produce both IL-17A and IL-4. The Journal of Allergy and Clinical Immunology 2010, 125:222-230. e221-e224.
31. Nowak E.C., Noelle R.J. Interleukin-9 as a T helper type 17 cytokine. Immunology 2010, 131:169-173.
32. Ciprandi G., De Amici M., Murdaca G., Fenoglio D., Ricciardolo F., Marseglia G., Tosca M. Serum interleukin-17 levels are related to clinical severity in allergic rhinitis. Allergy 2009, 64:1375-1378.
33. Wang H., Mobini R., Fang Y., Barrenas F., Zhang H., Xiang Z., Benson M. Allergen challenge of peripheral blood mononuclear cells from patients with seasonal allergic rhinitis increases IL-17RB, which regulates basophil apoptosis and degranulation. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 2010, 40:1194-1202.
34. Matsumoto Y., Noguchi E., Imoto Y., Nanatsue K., Takeshita K., Shibasaki M., Arinami T., Fujieda S. Upregulation of IL17RB during natural allergen exposure in patients with seasonal allergic rhinitis. Allergology International: Official Journal of the Japanese Society of Allergology 2011, 60:87-92.
35. Milovanovic M., Drozdenko G., Weise C., Babina M., Worm M. Interleukin-17A promotes IgE production in human B cells. The Journal of Investigative Dermatology 2010, 130:2621-2628.
36. Stummvoll G.H., DiPaolo R.J., Huter E.N., Davidson T.S., Glass D., Ward J.M., Shevach E.M. Th1, Th2, and Th17 effector T cell-induced autoimmune gastritis differs in pathological pattern and in susceptibility to suppression by regulatory T cells. Journal of Immunology 2008, 181:1908-1916.
37. Sergejeva S., Ivanov S., Lotvall J., Linden A. Interleukin-17 as a recruitment and survival factor for airway macrophages in allergic airway inflammation. American Journal of Respiratory Cell and Molecular Biology 2005, 33:248-253.
38. Hellings P.W., Kasran A., Liu Z., Vandekerckhove P., Wuyts A., Overbergh L., Mathieu C., Ceuppens J.L. Interleukin-17 orchestrates the granulocyte influx into airways after allergen inhalation in a mouse model of allergic asthma. American Journal of Respiratory Cell and Molecular Biology 2003, 28:42-50.
39. Wilson R.H., Whitehead G.S., Nakano H., Free M.E., Kolls J.K., Cook D.N. Allergic sensitization through the airway primes Th17-dependent neutrophilia and airway hyperresponsiveness. American Journal of Respiratory and Critical Care Medicine 2009, 180:720-730.
40. Besnard A.G., Sabat R., Dumoutier L., Renauld J.C., Willart M., Lambrecht B., Teixeira M.M., Charron S., Fick L., Erard F., et al. Dual role of IL-22 in allergic airway inflammation and its cross-talk with IL-17A. American Journal of Respiratory and Critical Care Medicine 2011, 183:1153-1163.
41. Chang Y., Al-Alwan L., Risse P.A., Roussel L., Rousseau S., Halayko A.J., Martin J.G., Hamid Q., Eidelman D.H. TH17 cytokines induce human airway smooth muscle cell migration. The Journal of Allergy and Clinical Immunology 2011, 127:1046-1053. e1041-e1042.
42. Chen J., Deng Y., Zhao J., Luo Z., Peng W., Yang J., Ren L., Wang L., Fu Z., Yang X., et al. The polymorphism of IL-17 G-152A was associated with childhood asthma and bacterial colonization of the hypopharynx in bronchiolitis. Journal of Clinical Immunology 2010, 30:539-545.
43. Lluis A., Schedel M., Liu J., Illi S., Depner M., von Mutius E., Kabesch M., Schaub B. Asthma-associated polymorphisms in 17q21 influence cord blood ORMDL3 and GSDMA gene expression and IL-17 secretion. The Journal of Allergy and Clinical Immunology 2011, 127:1587-1594. e1586.